Incidence and Prevalence of Patients with Myelodysplastic Syndromes (MDS) in Dusseldorf 1996-2005

被引：0
|
作者：
Neukirchen, J. [1 ]
Germing, U. [1 ]
Aul, C. [2 ]
Gattermann, N. [1 ]
Schoonen, M. [3 ]
Haas, R. [1 ]
机构：
[1] Univ Dusseldorf, Klin Hamatol Onkol & Klin Immunol, D-4000 Dusseldorf, Germany
[2] St Johannes Hosp Duisburg, Med Klin 2, Duisburg, Germany
[3] Amgen Ltd, Cambridge, England
来源：
MEDIZINISCHE KLINIK | 2010年 / 105卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：212 / 213
页数：2
相关论文
共 50 条
  • [41] Treatment Outcome of Patients with Myelodysplastic Syndromes (MDS) in Regular Care: Incidence of IPSS Risk Groups and Different Therapies in the German Outpatient MDS Registry
    Steinmetz, H. Tilman
    Boettger, Isolde
    Lathan, Bernd
    Sauer, Annette
    Moorahrend, Enno
    Severin, Kai
    Germing, Ulrich
    Schmitz, Stephan
    Gattermann, Norbert
    BLOOD, 2014, 124 (21)
  • [42] A Novel Prognostic Model in Heavily Treated Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Seastone, David J.
    Radivoyevitch, Tomas
    Gerds, Aaron T.
    Mukherjee, Sudipto
    Carraway, Hetty E.
    Advani, Anjali S.
    Kalaycio, Matt E.
    Rupp, Gina
    Colaluka, Kristin
    Hobson, Sean
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2014, 124 (21)
  • [43] COMBINATION OF ORAL RIGOSERTIB AND INJECTABLE AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Navada, S.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Fenaux, P.
    Petrone, M.
    Zbyszewski, P.
    Fruchtman, S.
    Silverman, L.
    LEUKEMIA RESEARCH, 2017, 55 : S30 - S30
  • [44] MEGAKARYOCYTOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WITH AND WITHOUT DEL(5+)
    PODOLAKDAWIDZIAK, M
    GEDDES, D
    BOWEN, D
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1990, 45 (02) : 115 - 116
  • [45] Influence of different treatment strategies on the prognosis of patients with myelodysplastic syndromes (MDS)
    Nachtkamp, K.
    Kuendgen, A.
    Strupp, C.
    Gattermann, N.
    Giagounidis, A.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2007, 31 : S30 - S30
  • [46] The incidence of Crohn's disease in Cardiff over the last 75 years: An update for 1996-2005
    Gunesh, S.
    Thomas, G. A. O.
    Williams, G. T.
    Roberts, A.
    Hawthorne, A. B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (03) : 211 - 219
  • [47] Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes (MDS).
    Yazji, S
    Giles, F
    Kantarjian, H
    Estey, E
    O'Brien, S
    Kurzrock, R
    BLOOD, 2002, 100 (11) : 794A - 794A
  • [48] Levels of circulating endothelial adhesion molecules in patients with myelodysplastic syndromes (MDS).
    Sudhoff, T
    Wehmeier, A
    Aul, C
    BLOOD, 1997, 90 (10) : 4051 - 4051
  • [49] A Personalized Prediction Model to Risk Stratify Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Komrokji, Rami S.
    Barnard, John
    Al-Issa, Karam
    Padron, Eric
    Madanat, Yazan F.
    Kuzmanovic, Teodora
    Abuhadra, Nour
    Steensma, David P.
    DeZern, Amy E.
    Roboz, Gail J.
    Garcia-Manero, Guillermo
    List, Alan F.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2017, 130
  • [50] Iron chelation treatment in patients with myelodysplastic syndromes (MDS): the experience of the Hellenic MDS Study Group
    Kouraklis, A.
    Symeonidis, A.
    Galanopoulos, A.
    Kaiafa, G.
    Tavernarakis, I.
    Tsirakis, G.
    Michali, E.
    Tsaftaridis, P.
    Loukidis, K.
    Aggelidis, A.
    Zoumbos, N.
    LEUKEMIA RESEARCH, 2009, 33 : S119 - S120
12345